Concepedia

Michael W. Pennington

MW

86

Publications

6.7K

Citations

46

H-Index

1989

Active since

Affiliations

Peptides International (United States)(Current)

Baylor College of Medicine

University of California, Irvine

Monash University

BioChem Technology (United States)

Michael W. Pennington is an author at Peptides International (United States) specializing in medicine, biochemistry, and natural sciences.

ORCID

Top concepts

Publications per year

1989–2023

86

Publications

86

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Christine Beeton, Heike Wulff, Nathan Standifer et al. · Proceedings of the National Academy of Sciences · 2006 · 525 citations · Full text

, , +18

Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease

Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza et al. · Molecular Neurodegeneration · 2018 · 445 citations · Full text

The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS

Heike Wulff, Peter A. Calabresi, Rameeza Allie et al. · Journal of Clinical Investigation · 2003 · 411 citations · Full text

, , +23

Selective blockade of T lymphocyte K<sup>+</sup>channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis

Christine Beeton, Heike Wulff, Jocelyne Barbaria et al. · Proceedings of the National Academy of Sciences · 2001 · 315 citations · Full text

ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide

Katalin Kálmán, Michael W. Pennington, Mark D. Lanigan et al. · Journal of Biological Chemistry · 1998 · 254 citations · Full text

, , +11

Rows per page

1–5 of 86